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ABSTRACT 
 
 
 
 
Paracetamol tablet is a well-known over the counter medicine and is widely 
available for consumers. For that reason, the originality of paracetamol tablets sold in 
the market is questionable. Even though pharmaceutical measures for ensuring that the 
manufactured medicines would comply fully with the standards were taken, cases 
involving counterfeit paracetamol products have been increasingly reported 
throughout the world. Hence, this present cross-sectional research which analysed 
BRAND X 500 mg paracetamol tablets sampled from varying outlets of different 
districts in Johor appears important for the relevant authorities to understand the 
current status of authenticity of such product and also for consumer protection. In this 
research, while the quality of samples was determined based on their active 
pharmaceutical ingredient (API) amounts using validated High Performance liquid 
chromatography (HPLC), their organisation and classification were done by Fourier 
Transform Infrared Spectroscopy (FTIR) coupled with Principal Component Analysis 
(PCA) and Linear Discriminant Analysis (LDA). Quality examination of the samples 
indicated a variability in qualities; (1) in-range (475-525 mg), (2) lower than range 
(324-466 mg) and (3) higher than range (532-598 mg). These indications were made 
according to British Pharmacopoeia (2013) which stated that preparation of 
paracetamol products must have 95-105% of paracetamol content. Despite being 
categorically different in the amounts of paracetamol contents as well as districts and 
outlets, PCA and LDA showed that all the samples were convoluted into a single 
group, which supports the idea that all BRAND X 500 mg paracetamol tablet samples 
in this present research may originate from a common source/manufacturer. However, 
discrimination between the lower than range and the higher than range samples by 
PCA and LDA (accountable for 91% of variances and 93% correct classification 
respectively) had resulted in successful separation between them. Therefore, analysis 
of BRAND X 500 mg paracetamol tablet samples and their discrimination prove to be 
significant for providing empirically robust scientific evidence for the relevant 
authorities to prevent increasing flooding of its counterfeit products especially in 
Malaysia. 
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ABSTRAK 
 
 
 
 
Tablet parasetamol merupakan ubat  terkenal yang boleh dibeli tanpa nasihat 
doktor di kebanyakkan kedai, oleh kerana  kewujudannya yang meluas dan mudah 
didapati oleh pengguna menyebabkan keasliannnya dipersoalkan. Walaupun tindakan 
farmaseutikal untuk memastikan ubat yang dihasilkan mematuhi standard yang di 
tetapkan telah diambil, kes-kes berkaitan pemalsuan produk-produk parasetamol 
dilaporkan semakin meningkat diseluruh dunia. Justeru itu, kajian keratan lintang ini 
yang dijalankan untuk menganalisis tablet parasetamol 500 mg JENAMA X yang 
disampel daripada pelbagai jenis kedai dan daerah yang berbeza di Johor adalah 
penting bagi pihak berkuasa yang berkaitan memahami status terkini keaslian produk 
tersebut dan juga untuk perlindungan pengguna. Dalam kajian ini, sementara kualiti 
sampel ditentukan berdasarkan kandungan farmaseutikal aktif (API) menggunakan 
kromatografi cecair berprestasi tinggi (HPLC), organisasi dan klasifikasi sampel 
dilakukan menggunakan spektroskopi transformasian fourier inframerah (FTIR) 
digandingkan dengan analisis komponen utama (PCA) dan analisis diskriminan linear 
(LDA). Pemeriksaan kualiti sampel menunjukkan kepelbagaian dalam kualiti, iaitu (1) 
dalam kelompok (475-525 mg), (2) rendah berbanding kelompok (324-466 mg) dan 
tinggi berbanding kelompok (532-598 mg). Indikasi-indikasi tersebut dibuat 
berpandukan British Pharmacopoeia (2013) yang menyatakan bahawa pembuatan 
produk parasetamol haruslah mempunyai 95-105% kandungan parasetamol. 
Walaupun berbeza secara kategori dari segi kandungan parasetamol serta daerah dan 
kedai, analisis menggunakan PCA dan LDA menunjukkan bahawa kesemua sampel 
berlingkar menjadi satu kumpulan (sama), seterusnya menyokong pandangan bahawa  
tablet parasetamol 500 mg JENAMA X yang di sampel dalam kajian ini 
berkemungkinan berasal daripada sumber/ pengilang yang sama. Namun, diskriminasi 
antara sampel rendah berbanding kelompok dan sampel tinggi berbanding kelompok 
menggunakan PCA dan LDA (membawa kepada 91% variasi dan 93% ketepatan 
klasifikasi secara respektif) berjaya menghasilkan n pemisahan antara dua kelompok 
tersebut. Oleh itu, analisis sampel 500 mg JENAMA X dan diskriminasinya adalah 
terbukti penting untuk memberikan bukti saintifik emperik yang kukuh untuk 
kegunaan pihak berkuasa yang berkaitan bagi mengelakkan peningkatan limpahan 
produk-produk JENAMA X yang palsu terutamanya di Malaysia.  
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CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1 Background of Study 
 
 
 During the past few decades, the production and distribution of pharmaceutical 
products have increased tremendously, in tandem with the ever-growing human 
population throughout the world (Tannoury and Attieh, 2017).  Among others, 
antipyretic medications like paracetamol and ibuprofen have been made available over 
the counter for maintaining human health and well-being (Lau et al., 2016).  Such 
medications must be of standard quality, safe and effective (Custer et al., 2015).  While 
stringent pharmaceutical measures for ensuring that the manufactured medicines 
would comply fully with the prevailing standards, instances wherein counterfeit 
medicines are recovered in the market has been gaining notoriety (Degardin et al., 
2015).  Review of literature reveals varying definitions for counterfeit drugs, with the 
one provided by the World Health Organisation (WHO) acquires popularity among 
clinicians (Jackson et al., 2010).  The same authors indicated that the WHO defines 
“counterfeit medicines as those that are deliberately and fraudulently mislabelled with 
respect to identity or source; their quality is unpredictable as they may contain the 
wrong amount of active ingredients or no active ingredients”.  The use of counterfeit 
medicines has been advocated as the probable culprit for a number of clinical 
conditions such as liver and kidney failures, especially when their concentrations 
exceeded that of the prescribed therapeutic ranges (Nor Aripin and Choonara, 2009).  
On the other hand, insufficient amount of active ingredients in counterfeit medicines 
2 
 
may result in ineffective treatment (Majid, 2008).  In this context, it has been argued 
that such counterfeit medicines are “manufactured in clandestine laboratories with no 
possibility of control” (Nayyar et al., 2012) although the truth remains unclear.    
 
 
Paracetamol (acetaminophen, N-acetyl-p-amino-phenol, C8H9NO2) has been 
regarded as the first line therapy for mild acute or chronic pain that is not relieved by 
non-pharmacological approaches like reassurance, rest, ice or heat pack (Belal et al., 
2009), and highly demanded by public as the practice of self-medication becomes 
common (British Pharmacopoeia, 2012).  It is available in various forms ranging from 
tablets, capsules, oral solution, oral suspension, and suppositories (Wilson et al., 
2011).  The recommended dosage of paracetamol for adults ranges between 500 mg to 
1000 mg for every 4 to 6 hours, up to a total daily dose of 4000 mg.  As for children, 
the recommended dosage is 15 mg/kg at every 4 to 6 hours, up to a total daily dose of 
2400 mg (Pasero and Stannard, 2012).  In this context, British Pharmacopoeia (2012) 
prescribed that a preparation should contain 95-105% of the stated amount of 
paracetamol for it to exert its effectiveness.  Being one of the widely available non-
prescription medicine, paracetamol has been reported as the most common drug used 
for self-poisoning in the United Kingdom as well as in many other countries (Simkin 
et al., 2012) including Malaysia (Fathelrahman et al., 2008).  Hepatic injury has been 
reported as the principal toxic effect of an extensive paracetamol misuse and overdose 
(Tan et al., 2015). 
 
 
Interestingly, the number of cases involving counterfeited paracetamol has 
been increasingly reported in the literature.  For example, GlaxoSmithKline in Kenya 
had discovered knock-offs of its best painkillers Panadol extra in the market (Business 
Daily, July 31, 2009), the death of 109 children in Nigeria upon receiving counterfeit 
paracetamol (Majid, 2008), as well as undetectable amount of paracetamol in 
paracetamol syrup in Pakistan (Ahmed, 2011).  While there is no specific scientific 
report on counterfeit paracetamol in Malaysia, the Sarawak State Health Department 
indicated that Panadol is one of “the commonly faked brands in the market” (Borneo 
Post online, May 20, 2015).  Therefore, specific empirical study focusing on this aspect 
in Malaysia merits public health consideration.   
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 In addition to possible ineffectiveness of these substandard paracetamol 
products to confer the desired pharmacological effects, the possibility that they contain 
higher amount of impurities e.g.  4-aminophenol (4-AP) (Akay et al., 2008) cannot be 
ruled out.  Apart from being nephrotoxic and teratogenic (Calinescu et al., 2012) 4-AP 
may undergo further degradation to form the genotoxic and carcinogenic 
benzoquinone (BQ) (Das et al., 2010) and hydroquinone (HQ) (DeCaprio, 1999).  
Exposure towards HQ has been associated with chromosomal aberrations, abnormal 
mitoses, formation of micronuclei, aneuploidy, deoxyribonucleic acid (DNA) strand 
breakage, and sister chromatid exchange (Hebeda et al., 2012).  Moreover, liver and 
stomach neoplasia as well as mononuclear cell leukaemia have also been attributed to 
the long term exposure of HQ (DeCaprio, 1999).  Apart from health implications, 
counterfeit paracetamol may lead to substantial economic loss (Degardin et al., 2014) 
and violation of consumer rights (Deisingh, 2004).   
 
 
 
 
1.2 Problem Statements 
 
 
 Studies on the quality of paracetamol tablets sold by retail pharmacies and/or 
supermarket in Malaysia were last reported in 2011, indicating variability in their 
quality (assessed by Near Infrared Spectroscopy (NIR)) (Said et al., 2011) as well as 
physical characteristics (viz. weight, hardness, friability, disintegration and 
dissolution) (Chandrasekaran et al., 2011).  In addition to the seven years elapsed, 
specific research focusing on the concentration of its active pharmaceutical ingredient 
(API) which is paracetamol, in the popularly marketed 500 mg tablets, especially those 
of blister packaging, sold by various types of outlets (e.g.  established pharmacy, 
convenience store and petrol station, as well as local grocery shops) at different 
locations within Malaysia remains unreported, so far.  The only available reliable 
source of literature being the scarce press statement by the local authority such as that 
reported by Borneo Post Online (May 20, 2015).  Moreover, because in Malaysia the 
500 mg paracetamol tablets are commonly sold as loose blister packaging (that does 
not have hologram attached to it), the authenticity of this pharmaceutical product can 
be questionable.  Such a lack of information may deprive public confidence on the 
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safety and effectiveness of consuming the 500 mg paracetamol tablets, accentuating 
the needs to undertake this empirical study to address such pertinent issue.   
 
 
In this regard, having the ability to differentiate the authentic and counterfeit 
500 mg paracetamol tablets appears imperative for consumer protection.  Despite 
being one of the popular over the counter medicine, review of literature reveals only 
two specific studies focusing on the use of chemometric techniques for differentiating 
paracetamol products from different manufacturers (Khanmohammadi et al., 2010; 
Said et al., 2011); one of which differentiated paracetamol products between Malaysia 
and the United Kingdom (Said et al., 2011).  While developing a database to 
differentiate paracetamol products, Said et al.  (2011) indicated substantial variability 
in the quality of the tablets purchased from the Malaysian pharmacy and supermarkets.  
Considering (1) such indication, and (2) because assuming that the current quality of 
paracetamol in Malaysia would remain the same can be misleading, providing 
empirically robust scientific evidence using principal component analysis (PCA) and 
linear discriminant analysis (LDA) for differentiating the genuine and counterfeit 500 
mg paracetamol tablets from different districts in Johor, Malaysia attempted here, 
acquires forensic significance.  Figure 1.1 represent the conceptual frameworks of this 
present research.   
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The quality examination of pharmaceutical products 
Physical Appearance Instrumentation 
Hologram 
(Olds et al., 
2011) 
Packaging 
(Ranneiri et 
al., 2014) 
Active Pharmaceutical ingredient 
(API) (Chandra et al., 2013) 
Quantitative Qualitative 
Impurities and 
Excipients (Akay 
et al., 2008) 
Label on packaging 
(Wondemagegnehu, 
1999) 
HPLC (Jain et al., 2011) 
Chemometrics analysis (Myakalwar 
et al., 2011) 
Chemical 
profiling 
(Chandrasekar
an et al., 2011; 
Note: Black and red arrows indicate this presence research approaches as well as existing techniques available from 
literatures for examining the quality of pharmaceutical products , respectively. 
Figure 1.1 The conceptual framework of this present research 
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1.3 Objective of Study 
 
 
The objectives of this present cross-sectional research conducted in the ten districts of 
Johor, Malaysia were: 
 
 
1. To determine the concentrations of paracetamol in BRAND X 500 mg 
paracetamol tablets sampled from the different outlets.   
2. To examine the quality of  BRAND X 500 mg paracetamol tablets according 
to their paracetamol contents. 
3. To study the organisation and classification of BRAND X 500 mg paracetamol 
tablets among the different outlets and districts.    
 
 
 
 
1.4 Scope of Study 
 
 
This cross-sectional present research was conducted during January to 
February 2017, involving BRAND X 500 mg paracetamol tablets (blister packaging) 
purchased from the different outlets (established Pharmacy A, Petrol Station A and 
Convenience Store A  as well as Local Grocery Shops A-C) in all the ten districts of 
Johor, Malaysia.  The districts were Johor Bahru, Mersing, Segamat, Pontian, Kota 
Tinggi, Kulai, Tangkak, Kluang, Muar and Batu Pahat.  Since, our attempts to obtain 
directly the genuine BRAND X 500 mg paracetamol tablet samples were ignored by 
the manufacturer, direct comparison with those purchased from the different outlets 
could not be made.  The concentration of paracetamol in the tablets was analysed using 
the High Performance Liquid Chromatography (HPLC) with Ultraviolet Visible (UV) 
detector, following method validation.  Parameters standardised during method 
validation included linearity and sensitivity as well as repeatability and reproducibility 
of the procedure.  All the samples were then divided into those of containing in-range, 
lower than range and higher than range paracetamol contents, as prescribed by the 
British Pharmacopeia (2012).  The samples were analysed using Attenuated 
Reflectance - Fourier Transform Infrared Spectroscopy (ATR-FTIR) for obtaining 
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